The Gluten Crazies are out of control and affecting menus in restaurants

Posted on March 2, 2018 by admin

April 26, 2015- By Steven E. Greer, MD

I was eating at a French restaurant recently, and the waiter asked me if I had any allergies, such as “gluten”. Continue reading →

Posted in - Opinion, Gastroenterology and liver, Harvard, Pediatrics | Leave a comment

Kick your smartphone app addiction in 2018

Posted on March 1, 2018 by admin

January 8, 2018- by Steven E. Greer, MD

I was one of the very earliest CrackBerry addicts in 2000. That was a term given to people constantly Continue reading →

Posted in - Opinion, Neurology, Neurosurgery, Ophthalmology, Pediatrics, Psychology Psychiatry, Rehab | Leave a comment

Mechanical heart valves provide much lower mortality than tissue valves in young patients

Posted on March 1, 2018 by admin

November 8, 2017- by Steven E. Greer, MD

Off the radar of Wall Street analysts is a new paper in the NEJM that shows mechanical heart valves, both aortic and mitral, impart much lower mortality than tissue valves in the youngest cohort of patients. This paper was not presented at the recent TCT or Euro PCR. Continue reading →

Posted in - Medical Devices, - NEJM, Cardiac surgery, Cardiology | Leave a comment

Is President Trump on amphetamines? (Yes, he is)

Posted on February 28, 2018 by admin

Update January 16, 2018- by Steven E. Greer, MD

President Trump’s doctor confirms my diagnosis made in the story below, which was that the slurred Continue reading →

Posted in - Opinion, - Pharma, - Policy, FDA, Internal Medicine, Neurology, Primary care medicine, Rehab | Leave a comment

Bending the cost curve of cancer care

Posted on February 26, 2018 by admin

May 25, 2011- Since the approval of Genentech’s costly Avastin in 2004, prominent oncologists have warned that Continue reading →

Posted in - Biotech, - Pharma, CMS, Oncology, VCU | Leave a comment

NBC begins alarming new series to promote the diagnosis of “mental illness” in children

Posted on February 24, 2018 by admin

December 11, 2017 Continue reading →

Posted in - Opinion, - Pharma, - Policy, CDC, Congress, FDA, Neurology, Neurosurgery, NIH, Pediatrics, Primary care medicine, Psychology Psychiatry, Rehab | Leave a comment

Did Hillary Clinton really faint from “dehydration” or does she have a chronic neurological condition?

Posted on February 24, 2018 by admin

September 12, 2016- by Steven E. Greer, MD

Once again, the Hillary Clinton campaign is on defense after another health scare from their Continue reading →

Posted in - Policy, Cardiology, Congress, Emergency medicine, Neurology, NYU, Ophthalmology, Primary care medicine, Radiology | Leave a comment

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer (FLAURA)

Posted on February 23, 2018 by admin

November 20, 2017- Interviewed by Steven E. Greer, MD

We interviewed Emory University oncologist Suresh S. Ramalingam, M.D. about his NEJM Continue reading →

Posted in - NEJM, Cardiac surgery, Emory, Oncology | Leave a comment

Oh my god, I have a disease!

Posted on February 21, 2018 by admin

March 21, 2014- This DTC TV drug ad medicalizing a non-disease really struck us as egregious

Posted in - Pharma, Congress, FDA | Leave a comment

US Senator calls for transparency in medical device pricing

Posted on February 14, 2018 by admin

Posted in - Medical Devices, Congress | Leave a comment

HBO’s John Oliver devotes 16-minutes on the Dr. Oz senate hearing

Posted on February 9, 2018 by admin

Posted in - Opinion, Cardiac surgery, Congress | Leave a comment

Hormone replacement therapy is safe and effective after all

Posted on January 31, 2018 by admin

November 14, 2017- Interviewed by Steven E. Greer, MD

We interviewed JoAnn Manson, MD, DrPH about her JAMA paper that followed the cohorts in Continue reading →

Posted in - JAMA, Cardiology, Diabetes and endocrinology, FDA, Geriatrics, Harvard, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Primary care medicine | Leave a comment

Football head injuries down after rules change

Posted on January 19, 2018 by admin

NFL-concussionUpdate January 20, 2015- The PBS news show Frontline has been tracking the number Continue reading →

Posted in - Opinion, - Policy, Neurosurgery, Primary care medicine, Psychology Psychiatry, Spine surgery, Sports medicine | Leave a comment

Increasing rates of double mastectomies in early stage breast cancer

Posted on January 15, 2018 by admin

November 22, 2013- Interviewed by Steven E. Greer, MD

David P. Winchester MD, Medical Director of Cancer Programs for the American College of Surgeons, Continue reading →

Posted in - Policy, Oncology, Plastic surgery | Leave a comment

The serious adverse events caused by antipsychotics

Posted on January 13, 2018 by admin

February 1, 2014 Continue reading →

Posted in - Pharma, FDA | Leave a comment

Steve Bannon and the epidemic of Baby Boomers with mental illness

Posted on January 5, 2018 by admin

January 5, 2017- by Steven E. Greer, MD

President Trump made news yesterday by issuing a statement firing back at Steve Bannon for allegations Continue reading →

Posted in - Opinion, - Pharma, - Policy, Geriatrics, Neurology, Psychology Psychiatry, Rehab | Leave a comment

CT-scan screening for heart disease fails to show benefit

Posted on January 5, 2018 by admin

March 23, 2015- Interviewed by Steven E. Greer, MD

We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke. Continue reading →

Posted in - NEJM, - Policy, Cardiology, CMS, Duke, Radiology | Leave a comment

What Steve Jobs would have invented if he had lived longer

Posted on January 4, 2018 by admin

Steve-JobsUpdate January 29, 2014- Apple posted Q4 earnings so big that they are incomprehensible. Continue reading →

Posted in - Medical Devices, - Opinion | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

Posted on January 4, 2018 by admin

May 23, 2017- interviewed by Steven E. Greer, MD

We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab Continue reading →

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment

The super shady methods of pricing generic drugs in America: case study- Sildenafil

Posted on January 4, 2018 by admin

Generic revatioMay 15, 2016- by Steven E. Greer, MD

The last I read, Teva and Mylan were not supposed to launch their approved generic of Viagra (sildenafil) Continue reading →

Posted in - Generics, - Opinion, - Pharma, CMS, Congress, FDA | Leave a comment